You are here
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
SBC: DxDiscovery Incorporated Topic: CBD14105
The purpose of this contract is to develop high affinity antibodies that are specific to Burkholderia surface expressed polysaccharides. These monoclonal antibodies (mAbs) can then be used to develop diagnostics and therapeutics for melioidosis and glanders; two infectious diseases caused by the Tier 1 biothreats Burkholderia pseudomallei and mallei, respectively. The SBIR funded work to date deve ...SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
SBC: Oceanit Laboratories, Inc. Topic: SOCOM172002
Oceanit proposes to develop novel nutraceutical and/or pharmaceuticals to enhance important USSOCOM Multi-Purpose Canine (MPC) performance attributes that optimize their performance, improve recovery time when wounded and increase their survivability.SBIR Phase I 2018 Department of DefenseSpecial Operations Command